Roberto Renaville

CER Groupe FUP engages in the fields of biomedical research, the food industry and agricultural training. The company was founded in 1980 and is headquartered in Aye, Belgium.

Robelga SRL provides business and management advisory services. The private company is based in Uccle, Belgium. The Belgian company was founded in 2008. The CEO is Robert Taub.

Brussels Life Science Incubator SA leases laboratory and medical research spaces for businesses. It offers administrative spaces, laboratory spaces, shared areas, logistics, technological and scientific, and business services. The company was founded on August 1, 2008 and is headquartered in Brussels, Belgium.

SYnAbs SA specializes in generating unique secondary monoclonal antibodies that target a variety of repertoires including mouse, human, rat, llama, rabbit, and guinea pig. The company is based in Gosselies, Belgium. The Belgian company focuses on generating highly specific therapeutic and R & D monoclonal antibodies that target difficult and poor immunogenic antigens for PK/PD, immunogenicity assays, and therapeutic applications. The company also specializes in generating monoclonal antibodies against haptens, GPCR, complex transmembrane proteins, and other difficult antigens. The company was founded in 2015 by Yannic Nizet, Pierre Gianello. The CEO is Julien Isoard.

HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut..

HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY.

Herpain Urbis Retail Holding SA is an investment holding Belgian company. The private company is based in Uccle, Belgium. The company was founded in 2015. Yvan Neirinckx has been the CEO of the company since 2015.

Man & Science NV is a Belgian medical device company that develops a novel, minimally invasive, battery-free neurostimulation system to reduce the pain and frequency of severe headache attacks. The company is based in Mont-Saint-Guibert, Belgium, and has subsidiaries in Norway. The company's therapies allow headache patients to return to a normal, pain-free life. The company's team consists of experienced scientists, engineers, clinical research specialists, business experts, and successful start-up founders and entrepreneurs. The company was founded in 2011 by Robert Taub, and Fabian Suarez Gonzalez has been the CEO of the company since 2022.

LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel.

OVVI Diagnostics France SE develops diagnostic tests for cardiovascular diseases. The firm’s technology include MIAtek technology, MIAplex technology and instruments for emergency diagnostic test for cardio-vascular diseases. The company was founded by Petr Nikitin, Jean-Patrick Voisin and Daniel Bernard in 2003 and is headquartered in Paris, France.

OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ.

Recoly NV operates as a biotech company focusing on the discovery, development and commercialization of drug enhancing technologies that are used to create bio-better drugs. Its pipeline includes multiple products; all based on their proprietary technologies, in different development stages from marketing authorization filing through pivotal to pre-clinical studies. The company was founded by Robert Taub in 1992 and is headquartered in Brussels, Belgium.

Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland.